Marksans Pharma’s arm receives Marketing Authorisation for product Cyanocobalamin

06 Nov 2023 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem has received Marketing Authorisation for the product Cyanocobalamin 50mg film coated tablets from UK MHRA. Earlier, the company’s wholly owned subsidiary -- Time-Cap Laboratories, Inc. had received Establishment Inspection Report (EIR) from US Food & Drugs Administration (USFDA) for audit conducted in October 2023. No 483's were issued during the Audit. 

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×